Remote Patient Monitoring & Wearables

Remote patient monitoring (RPM) means collecting health information from a person outside a clinic, usually at home, and sending it to a care team. One systematic review counts any programme where at least one sensor gathers patient data remotely for clinicians to use in decisions. Two groups are affected: patients and carers, who take measurements on their own, and clinicians, who review readings from many people they may never see in a waiting room. This article defines the domain and points to the topic articles that cover its parts in depth.

What it covers

The devices are often wireless. The US Food and Drug Administration (FDA) describes wireless medical devices (Wi-Fi, Bluetooth, cellular), names remote monitoring as one use, and points to home monitoring of chronic disease in older people. A service usually pairs a device or app for the patient with software that lets staff review the data. Programmes in the sources read for this article include:

• Home blood pressure monitoring: a hospital programme in the Netherlands used validated Bluetooth devices and asked patients to measure twice a day during active weeks.
• Symptom reporting after hospital discharge, as in a programme at a US cancer centre.
• Smartphone symptom reporting in mental health, tried in a small English study.

Who uses it

• Patients and carers take the measurements, set up the equipment and sometimes enter symptoms. Digital confidence, language and cost vary widely.
• Clinicians and care teams, including nurses who process alerts, decide who needs contact and when.
• Administrators, IT staff and service leads connect the service to other systems and keep it funded.
• Device makers and platform providers supply the hardware and software, and some of their products fall under medical-device rules.

What drives the design

The shaping factor is that care happens away from the clinic while data keeps arriving. Nobody is present to correct a measuring technique or explain a reading, and the care team sees a stream of numbers rather than a person. Two interfaces therefore have to work as one system: the patient's device or app, and a dashboard that ranks many patients. Choices about thresholds (the value at which a system raises an alert), about what a missing reading means, and about who is told follow from this.

Where the risks and constraints are

• Alert volume. In a Rotterdam blood pressure programme, alerts were generated for more than half of all measurements. The platform handled most automatically; of the actions staff took, roughly three quarters were administrative rather than clinical. Alert fatigue means staff respond less as too many alerts arrive. This is one programme.
• Workload. In a cancer programme, clinicians who answered a survey mostly found the system easy to learn, yet most said it did not reduce their workload. Staff experience was examined in only 20 of 158 papers in one review, so less is known about the care-team side.
• Gaps and connectivity. The FDA notes that nearby wireless devices can interrupt a wireless medical device and cause data loss. Staff in a Victorian, Australia, study questioned whether patients have internet or even a landline at home. A missing reading can be information, not only a fault.
• Set-up, skills and cost. The same Victorian study named low digital literacy, especially among older adults, language barriers, and out-of-pocket costs for devices and data plans. A scoping review of hypertension and diabetes programmes also lists digital health literacy gaps among patient hurdles.
• Burden and anxiety. In a study of eight people using a symptom-monitoring app, some felt repeatedly reminded of their difficulties, others found graphs helped them notice patterns, and some worried about privacy and being seen by others.
• Device accessibility. A 2012 measurement study found wide differences in display contrast and font size across glucose meters and blood pressure monitors, and a 2007 test found speech output on only two of nine blood pressure monitors. Both covered devices sold at the time.
• Regulation and privacy. Some monitoring devices are regulated as medical devices. The FDA's enforcement-policy guidance for non-invasive remote monitoring devices, issued October 2023, sets out when a manufacturer can add home use or wireless remote-monitoring capability to an already-cleared device without a new premarket submission. Which rules apply depends on the country and the product, and is a question for specialists.

Where to read next

• Clinical vs Patient Interfaces: one set of data shown to two very different readers.
• Data Visualisation & Health Metrics: how ranges, charts, colour and gaps in home readings are drawn.
• Trust, Ethics & Safety: why alerts and thresholds are safety questions, and who is accountable.
• Design for Vulnerable Users: older adults, low digital confidence, and people who are unwell.
• Accessibility & Regulation: accessibility of devices and apps, and where the rules sit.
• Process & Research: testing with real patients and clinicians, including care-team staff.

Related Showcase card

• Consent, not coercion - the one RPM-domain card built so far - an onboarding consent screen for a symptom-tracking app.